2-hydroxy-2-butyl-hexylamine | 57728-33-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-hydroxy-2-butyl-hexylamine
• 英文别名: 2-Hydroxy-2-butyl-hexylamin；5-(Aminomethyl)-5-nonanol；5-(aminomethyl)nonan-5-ol
• CAS: 57728-33-3
• 化学式: C₁₀H₂₃NO
• 分子量: 173.299
• InChiKey: WKCFQCKIWBAXHS-UHFFFAOYSA-N

物化性质

• 沸点：
  279.8±13.0 °C(Predicted)
• 密度：
  0.889±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-hydroxy-2-butyl-hexylamine 在 对甲苯磺酸 作用下， 以 苯 为溶剂， 生成 N-(2-butyl-hex-2-enyl)-acetamide
  参考文献：
  名称：

  Guignard,A.; Lamant,M., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1977, vol. 285, p. 203 - 206

  摘要：

  DOI：
• 作为产物：
  描述：

  2-(2-Butyl-2-hydroxy-hexylamino)-cyclopent-1-enecarbonitrile 在 盐酸 作用下， 生成 2-hydroxy-2-butyl-hexylamine
  参考文献：
  名称：

  Lamant,M.; Guignard,A., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1975, vol. 281, p. 123 - 126

  摘要：

  DOI：

文献信息

• Synthesis and Use of Achiral Oxazolidine-2-thiones in Selective Preparation of<i>trans</i>2,5-Disubstituted Tetrahydrofurans
  作者：Gaël Jalce、Xavier Franck、Bruno Figadère

  DOI：10.1002/ejoc.200800907

  日期：2009.1

  The use of achiral N-acetyloxazolidine-2-thiones in the C-glycosylation of lactol acetates has allowed us to prepare with high diastereoselectivity the expected trans 2,5-disubstituted tetrahydrofurans. A study based on the role of the steric hindrance of the N-acetyloxazolidine-2-thiones is reported. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)

  在乳醇乙酸酯的 C-糖基化中使用非手性 N-乙酰恶唑烷-2-硫酮使我们能够以高非对映选择性制备预期的反式 2,5-二取代四氢呋喃。报道了一项基于 N-乙酰恶唑烷-2-硫酮的空间位阻作用的研究。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
• [EN] TARGETED DELIVERY TO BETA CELLS<br/>[FR] ADMINISTRATION CIBLÉE À DES CELLULES BÊTA
  申请人：CHOUDHARY AMIT

  公开号：WO2018195486A1

  公开（公告）日：2018-10-25

  The disclosure includes zinc prodrugs for targeted delivery of therapeutic, diagnostic or imaging agents to β-cells and methods of use therefor. The disclosure also includes targeted delivery of small molecules to β-cells that stabilize and activate CRISPR effector proteins comprising at least one destabilization domain, to enable CRISPR-based genome editing and transcriptional activation or repression in β-cells.

  本公开内容包括用于将治疗性、诊断性或成像剂靶向递送至β细胞的锌前药及其使用方法。本公开内容还涉及将小分子靶向递送至β细胞，这些小分子能够稳定并激活至少含有一个不稳定域的CRISPR效应蛋白，从而在β细胞中实现基于CRISPR的基因编辑和转录激活或抑制。
• Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components
  申请人：Maas Wiebke

  公开号：US20070210288A1

  公开（公告）日：2007-09-13

  The invention relates to mixtures composed of dialkylphosphinic esters and of further components, which comprise A) from 98 to 100% by weight of monocarboxy-functionalized dialkylphosphinic esters of the formula (I) in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are identical or different and, independently of one another, are H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, and/or phenyl, Y is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, phenyl, 2-hydroxyethyl, 2,3-dihydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 4-hydroxybutyl, 3-hydroxybutyl, 2-hydroxybutyl, and/or 6-hydroxyhexyl, allyl, and/or glycerol, X is H, Li, Na, K or NH 4 , or X is defined as for Y, and then X and Y are two identical radicals or two different radicals of the above organic radicals, and B) from 0 to 2% by weight of halogens, where the entirety of the components always amounts to 100% by weight.

  该发明涉及由二烷基膦酸酯和进一步组分组成的混合物，其中包括A) 公式（I）的单羧基功能化二烷基膦酸酯，其占98至100重量％，其中R1、R2、R3、R4、R5、R6和R7相同或不同，并且独立地为H、甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基和/或苯基，Y为甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、苯基、2-羟乙基、2,3-二羟基丙基、2-羟基丙基、3-羟基丙基、4-羟基丁基、3-羟基丁基、2-羟基丁基和/或6-羟基己基、烯丙基和/或甘油，X为H、Li、Na、K或NH4，或者X如Y所定义，然后X和Y是上述有机基团的两个相同基团或两个不同基团，以及B) 卤素，其占0至2重量％，其中所有组分的总和始终为100重量％。
• Composition for separating mixtures
  申请人：Procter Ian

  公开号：US20070249502A1

  公开（公告）日：2007-10-25

  Therefore, there is provided herein in one specific embodiment a composition comprising: a) at least one silicone surfactant, and where silicone of silicone surfactant (a) has the general structure of: M a 1 M b 2 D c 1 D d 2 T e 1 T f 2 Q g ; and, 2≦( a+b+c+d+e+f+g )≦100; and, b) a mixture comprising an aqueous phase, a solid filler phase and optionally an oil phase that is substantially insoluble in said aqueous phase.

  因此，在一个具体实施例中提供了一种组合物，包括：a) 至少一种硅表面活性剂，其中硅表面活性剂(a)的硅具有以下一般结构：Ma1Mb2Dc1Dd2Te1Tf2Qg；以及，2≦(a+b+c+d+e+f+g)≦100；和，b) 一种混合物，包括水相、固体填料相和可选地在所述水相中基本不溶的油相。
• ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER
  申请人：INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY

  公开号：US20190031586A1

  公开（公告）日：2019-01-31

  An organic compound, a three-dimensional organic structure formed by using the organic compound, a separation sieve and an optical layer having the organic structure, and an optical device having the optical layer as an optical amplification layer are provided. The organic structure includes a plurality of organic molecules self-assembled by non-covalent bonding. Each of the unit organic molecules has an aromatic ring, a first pair of substituents being connected to immediately adjacent positions of substitutable positions of the aromatic ring, and a second pair of substituents being connected to immediately adjacent positions of remaining substitutable positions of the aromatic ring. The unit organic molecules are self-assembled by van der Waals interaction, London dispersion interaction or hydrogen bonding between the first and the second pairs of the substituents and by pi-pi interactions between the aromatic rings.

  提供一种有机化合物，通过使用该有机化合物形成的三维有机结构、分离筛和具有该有机结构的光学层，以及具有光学层作为光学放大层的光学器件。该有机结构包括通过非共价键自组装的多个有机分子。每个单元有机分子具有芳香环，第一对取代基连接到芳香环的可取代位置的相邻位置，第二对取代基连接到芳香环的剩余可取代位置的相邻位置。单元有机分子通过范德华力相互作用、伦敦分散相互作用或氢键作用于第一和第二对取代基之间的π-π相互作用而自组装。